5 Best Managed Healthcare Stocks To Watch For 2014

This morning the Thomson Reuters/University of Michigan preliminary reading on consumer confidence was released, and it indicated that the average American is becoming gloomier about the health of the economy. The reading dropped from 78.6 in March to 72.3 in April. Economists were expecting the index to hold steady at 78.5. Other measures have also slipped recently: The barometer of current economic conditions fell from 90.7 to 84.8, and the gauge of consumer expectations dropped from 70.8 to a 64.

While the consumer sentiment report usually garners the most attention, investors should view the reports as a whole in order to gain a comprehensive picture of the economy. Right now, that picture doesn't look so good, therefore the markets are trading lower today. As of 12:55 p.m. EDT the Dow Jones Industrial Average (DJINDICES: ^DJI  ) is off by 25 points, or 0.17%. The S&P 500 is down 0.41%, while the NASDAQ has lost 0.34%.

Shares of JPMorgan Chase (NYSE: JPM  ) are flat, having recovered from earlier losses after the company announced earnings this morning. The company beat on earnings per share, but revenue decreased by 3% to $25.8 billion. Additionally, the company warned that net interest margins will continue to be pressured and will likely put strain on revenue in the future.

Top 5 Dow Dividend Companies To Watch For 2015: Canon Inc (CAJ)

Canon Inc. (Canon), incorporated on August 10, 1937, is a manufacturer of network digital multifunction devices (MFDs), plain paper copying machines, laser printers, inkjet printers, cameras and steppers. Canon sells its products principally under the Canon brand name and through sales subsidiaries. Canon has manufacturing subsidiaries in variety of countries, including the United States, Germany, France, Taiwan, China, Malaysia, Thailand and Vietnam. Canon operates its business in three segments: the Office Business Unit, the Consumer Business Unit, and the Industry and Others Business Unit. On February 19, 2010, Canon acquired shares of OPTOPOL Technology S.A. On March 9, 2010, Canon acquired shares of Oce N.V. In May 2011, the Company incorporated Canon Information and Imaging Solutions, Inc.

Office Business Unit

Canon manufactures, markets and services a range of monochrome network digital MFDs, color network digital MFDs, office copying machines and personal-use copying machines. Canon�� lineup of digital MFDs include the imageRUNNER (iR) series, which performs a range of functions, such as copying, printing, scanning, faxing and data-sharing functions on the Internet and customer intranets. Canon offers color network digital MFDs for users ranging from professional graphic designers to business offices. Canon�� MFDs and color digital MFDs are available in the print-on-demand market.

Developed and fostered by Canon, laser beam printers are standard output peripherals for offices. Canon has adopted a user-replaceable toner cartridge system containing optical components. Most of Canon�� laser beam printer sales are on an original equipment manufacturing (OEM) basis. The Office Business Unit also includes the related sales of paper and chemicals, service and replacement parts.

The Company competes with Xerox Corporation/Fuji Xerox Co., Ltd., Ricoh Company, Ltd., Konica Minolta Holdings, Inc., Hewlett-Packard Company and Lexmark Internationa! l Inc.

Consumer Business Unit

Canon manufactures and markets digital cameras and digital video cameras as well as lenses and various other camera accessories. Canon released the EOS-1D Mark IV for professionals in December 2009. This model includes a newly developed approximately 16-megapixel APS-H size CMOS sensor and dual DIGIC 4 and features an expanded range of ISO settings for normal use between 100 and 12800, achieving beautiful images with low noise levels throughout the entire ISO range. Canon markets a variety of scanners for a spectrum of user needs, including image scanners in the CanoScan LiDE series using Contact Image Sensor (CIS) and scanners with Charge-Coupled Devices (CCD) for high resolution. CIS is a close-contact method that allows for a significant reduction in scanner weight and size.

The Company competes with Nikon Corporation, Sigma Corporation, Sony Corporation, Panasonic Corporation, Matsushita Electric Industrial Co.; Ltd., Victor Company of Japan, Ltd., Sanyo Electric Co., Ltd., Samsung Electronics Co., Ltd., Hewlett-Packard Company and Seiko Epson Corporation.

Industry and Others Business Unit

Medical imaging equipment sold by Canon includes X-ray image sensors, retinal cameras, autorefractometers and image-processing equipment for computerized systems. Canon�� pioneering digital radiography system takes X-ray photography and medical imaging into the digital age. Other Canon products such as electronic components are sold primarily to equipment manufacturers. These components include magnetic heads for audio and video tape recorders and micro-motors for printers and other components. Canon also offers business information products, which primarily consist of personal computers, servers, document scanners, calculators and micrographic equipment. Personal computers and servers sold by Canon are manufactured by third parties under the manufacturers��own brand names.

The Company competes with Ni! kon Corpo! ration and ASML Holding N.V.

Advisors' Opinion:

• [By Daniel Inman]

  In Japan, Canon (JP:7751) � (CAJ) �fell 1% after it lowered its full-year net profit forecast to 楼240 billion from a previous estimate of 楼260 billion set in July. Mitsubishi Motors Corp. (JP:7211) � (MMTOF) �added 1.9% after the car company increased its profit outlook.

5 Best Managed Healthcare Stocks To Watch For 2014: Furiex Pharmaceuticals Inc (FURX)

Furiex Pharmaceuticals, Inc. is a drug development collaboration company. The Company�� product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. Its programs include Priligy, Alogliptin Nesina, Alogliptin/Actose Combination, Alogliptin/Metformin Combination, Fluoroquinolone, Mu Delta and PPD 10558. In November 2011, it acquired full exclusive license rights to develop and commercialize the compound MuDelta under its existing development and license agreement with Janssen Pharmaceutica N.V.

Priligy (dapoxetine) is a drug developed for the on-demand treatment of premature ejaculation (PE). Dapoxetine is a short-acting, selective serotonin reuptake inhibitor (SSRI) designed to be taken only when needed one to three hours before sexual intercourse is anticipated rather than every day. Nesina (alogliptin) is a drug for the oral treatment of type 2 diabetes (T2D). Alogliptin is a DPP-4 inhibitor that slows the inactivation of incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP).

Fluoroquinolone drug candidate is a Phase II-ready novel fluoroquinolone antibiotic that is being developed by the Company for the treatment of complicated skin and skin structure infections, such as abscesses that occur deep in the skin layers and respiratory infections. This antibiotic has a spectrum of activity and is able to treat methicillin-resistant staphylococcus aureus (MRSA) infections. The Company is developing both oral and intravenous (IV) formulations. The Company is developing Mu Delta for treatment of diarrheal predominant irritable bowel syndrome (d-IBS). The Company is conducting a Phase II study on an oral formulation of Mu Delta.

The Company is developing PPD 10558 for the treatment of dyslipidemia. PPD 10558 has shown muscle safety in preclinical studies by minimizing the delivery of the drug to the muscle. The Company has filed an inve! stigational new drug (IND) application with the United States Food and Drug Association and completed five clinical studies.

Advisors' Opinion:

• [By John Udovich]

  Yesterday, small cap drug development collaboration company Furiex Pharmaceuticals Inc (NASDAQ: FURX) surged 129.91% after announcing that its experimental drug had alleviated diarrhea and abdominal pain caused by irritable bowel syndrome in two studies, meaning its worth taking a closer look at the stock because that�� a condition that effects millions of people (with no other effective drug to treat it) plus take a look at the�performance of biotech benchmarks iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).

• [By Michael Calia]

  Furiex Pharmaceuticals Inc.(FURX) said its treatment for diarrhea-predominant irritable bowel syndrome showed simultaneous improvements in stool consistency and abdominal pain in two Phase III studies. The drug developer’s shares surged 78% to $82 in recent premarket trading.

• [By Jake L'Ecuyer]

  Top Headline
  Forest Laboratories (NYSE: FRX) announced its plans to buy Furiex Pharmaceuticals (NASDAQ: FURX) for up to $1.46 billion. Forest will pay around $95 per share, or around $1.1 billion in cash. Forest Labs will also pay up to $30 per share, or around $360 million in a contingent value right. The deal is projected to close in the second or third quarter of 2014.

5 Best Managed Healthcare Stocks To Watch For 2014: Banco Santiago S.A.(SAN)

Banco Santander-Chile provides commercial and retail banking services to corporate and individual customers in Chile. The company offers time and demand deposits, checking accounts, and debit card accounts, as well as savings products; and peso and foreign currency denominated loans to finance various commercial transactions, trade, foreign currency forward contracts, and credit lines. Its loan portfolio comprises consumer loans, auto loans, residential mortgage loans, mutual funds, foreign trade financing, mortgage loans, and commercial loans. The company also provides factoring, credit cards, cash management, treasury services, short?term financing and funding, interest rate and foreign currency derivatives, and securitization services. Further, it offers various financial services, including leasing, financial leasing, financial advisory, mutual fund management, securities brokerage, insurance brokerage, and investment management services. As of December 31, 2010, the company had a branch network of 504 branches. Banco Santander-Chile was founded in 1977 and is headquartered in Santiago, Chile.

Advisors' Opinion:

• [By Sean Williams]

  For investors with more of a penchant for risk who are willing to bet against individual companies, they might consider angling a short sale against a large EU banking giant such as Banco Santander (NYSE: SAN  ) �or focus on a Greece-based bank like the National Bank of Greece (NYSE: NBG  ) .

• [By rusticnomad]

  Brocade Communications (BRCD) is another company that provides solutions similar to EMC, but it is a smaller player. Brocade earns 50% of its total revenue from its core service of storage area networks (SAN). However, it faced a 7% decline in revenue in the second quarter from the prior year period. This can be concerning for investors. With major players like Cisco (CSCO), Brocade faces fierce competition for its core business and the company might be in for tough times.

• [By Dan Carroll]

  That doesn't make either of these nations a safe bet for investors -- and especially not Spain, with its skyrocketing unemployment rate and bleak prospects for real economic growth in the near future. Still, that doesn't mean there aren't deals to be found among the best companies in these countries. Banco Santander (NYSE: SAN  ) has lost more than 11% year to date, but this financial firm has diversified well away from Europe's fiscal mess and toward developing Latin America, making the bank stock an intriguing emerging-markets play. With a massive 10.8% dividend yield and an optimistic earnings projection for the year, Santander isn't without appeal for investors. Still, Spain's risky economic situation makes nearly any stock from the country -- even a geographically diversified one -- a tough call.

• [By fedezaldua]

  Santander�(SAN)'s dividend yield, at an expected 9%, is the highest among large banking institutions, but its payout ratio is as high as it gets at an expected 119% for 2014 ��down from 132% in 2013. As a matter of fact, I would not expect the bank to have a dividend payout ratio below 100% until 2016. Nevertheless, the bank's chairman ��Emilio Botin ��is very much committed to sustaining Santander's dividend and we should not expect this policy to change in the foreseeable future unless the Bank of Spain forbids Santander to keep on distributing cash at the current rate.

5 Best Managed Healthcare Stocks To Watch For 2014: Newcrest Mining Ltd (NCM)

Newcrest Mining Limited (Newcrest) is a gold, copper and silver producer that has operations and exploration projects in Australia, the Pacific region, Asia and West Africa. The Company�� segments include Cadia Valley, Telfer, Gosowong, Lihir, Hidden Valley JV, West Africa (includes Bonikro operations and exploration and evaluation activities in Cote d��voire) and Exploration and Other. Exploration and Other mainly consists of projects in the exploration, evaluation and feasibility phase and includes Namosi in Fiji, Wafi Golpu in Papua New Guinea (PNG), and Marsden and O��allaghans in Australia. Cadia Valley Operations (CVO) is a gold mining operation and is 100% owned by Newcrest. It is located approximately 25 kilometers from the city of Orange in central west New South Wales and is 250 kilometers west of Sydney. Advisors' Opinion:

• [By Jonathan Burgos]

  Raw-material producers advanced. Rio Tinto climbed 4.3 percent to A$54.32 in Sydney. Newcrest Mining Ltd. (NCM), Australia�� biggest gold producer, rose 4.8 percent to A$16.65, paring its biggest weekly loss since October 2008. BHP Billiton Ltd., the world�� largest mining company, gained 2.5 percent to A$31.40.